EUVIMEDEUVIMED entdecken
Crossref

Integrative transcriptomics and metabolomics reveal distinct metabolic reprogramming in luminal and triple-negative breast cancer cells

Preeti Ranawade, Babasaheb Sonwane, Ganesh Bose, Revati Jadhav, Rakesh Joshi iD, Smriti Mittal

Molecular Omics · 2026

DOI: 10.1093/momics/aaiaf003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Omics, 2026. Verfasst von Preeti Ranawade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Savitribai Phule Pune University, Pune 411007, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Metabolomics, Transcriptome. Die Arbeit nennt 45 Literaturangaben. Gefördert von: SERB-SURE, SERB, Government of India, Savitribai Phule Pune University RUSA-2.0.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer subtypes exhibit significant molecular and metabolic heterogeneity, influencing their aggressiveness and therapeutic responses. Among them, triple-negative breast cancer (TNBC) is highly aggressive and often resistant to conventional therapies. To investigate the metabolic programming of this aggressiveness, we conducted an integrated transcriptomics and metabolomics analysis comparing the MCF-7 (luminal A, ER+/PR+) and MDA-MB-231 (TNBC) breast cancer cell lines. Transcriptome analysis of MCF-7 and MDA-MB-231 revealed the differential expression of genes involved in key metabolic pathways. Metabolomics data, further corroborated by transcriptomics, suggest pathway enrichment in beta-alanine, histidine, glutathione, nucleotide metabolism, and the tricarboxylic acid cycle. MDA-MB-231 cells displayed a metabolically aggressive phenotype with enhanced oxidative phosphorylation, redox adaptation, and nucleotide turnover. In contrast, MCF-7 cells showed a more regulated amino acid and redox metabolism profile. The integration of transcriptomic and metabolite profiles highlighted potential metabolic vulnerabilities in TNBC, offering insights into subtype-specific differences at the molecular level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMetabolomicsTranscriptomeHumansMetabolic ReprogrammingFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticMDA-MB-231 CellsMCF-7 CellsMultiomicsMetabolomeCell Line, Tumor

Autor:innen und Institutionen

  • Department of Biotechnology, Savitribai Phule Pune University, Pune 411007, India.
  • Biochemical Science Division, CSIR-National Chemical Laboratory, Pune 411008, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

ORCID-Profile: Rakesh Joshi

Förderung

  • SERB-SURE
  • SERB, Government of India
  • Savitribai Phule Pune University RUSA-2.0
  • CSIR, Government of India
  • SARTHI research fellowship-CSMNRF-2021, GOM, India
  • CSIR-JRF and SRF (Council of Scientific and Industrial Research-GoI)

Zitieren

APA

Ranawade, P., Sonwane, B., Bose, G., Jadhav, R., Joshi, R., & Mittal, S. (2026). Integrative transcriptomics and metabolomics reveal distinct metabolic reprogramming in luminal and triple-negative breast cancer cells. Molecular Omics. https://doi.org/10.1093/momics/aaiaf003

Vancouver

Ranawade P, Sonwane B, Bose G, Jadhav R, Joshi R, Mittal S. Integrative transcriptomics and metabolomics reveal distinct metabolic reprogramming in luminal and triple-negative breast cancer cells. Molecular Omics. 2026. doi:10.1093/momics/aaiaf003

BibTeX
@article{Ranawade2026,
  author = {Ranawade, Preeti and Sonwane, Babasaheb and Bose, Ganesh and Jadhav, Revati and Joshi, Rakesh and Mittal, Smriti},
  title = {Integrative transcriptomics and metabolomics reveal distinct metabolic reprogramming in luminal and triple-negative breast cancer cells},
  journal = {Molecular Omics},
  year = {2026},
  doi = {10.1093/momics/aaiaf003}
}
Kostenlos starten →